Sprycel (Chronic Myeloid Leukemia)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
3 Disease Overview 10
3.1 Etiology and Pathophysiology 10
3.1.1 Etiology 10
3.1.2 Pathophysiology 11
3.1.3 Clinical Staging 13
3.1.4 Prognosis 14
3.1.5 Quality of Life 15
3.2 Symptoms 16
4 Disease Management 17
4.1 Global Trends 17
4.1.1 Treatment Overview 17
4.1.2 Diagnostic Tests 20
4.1.3 Genetic Testing 21
4.1.4 Monitoring Patient Response to Treatment 23
4.1.5 Future Directions: Discontinuation Therapy 26
5 Competitive Assessment 28
5.1 Overview 28
5.2 Strategic Competitor Assessment 29
6 Product Profile – Sprycel (dasatinib) 32
6.1 Overview 32
6.2 Efficacy 34
6.3 Safety 35
6.4 SWOT Analysis 36
6.5 Forecast 37
7 Appendix 39
7.1 Bibliography 39
7.2 Abbreviations 42
7.3 Methodology 45
7.4 Forecasting Methodology 45
7.4.1 Diagnosed CML patients 45
7.4.2 Drug-treated Patients on X Line of Therapy 46
7.4.3 General Pricing Assumptions 46
7.4.4 Compliance Assumptions for Oral TKIs 48
7.4.5 Individual Drug Assumptions 49
7.4.6 Generic Erosion 49
7.5 Physicians and Specialists Included in this Study 50
7.6 Survey of High Prescribing Physicians 51
7.7 About the Authors 52
7.7.1 Authors 52
7.7.2 Epidemiologists 53
7.7.3 Global Director of Epidemiology and Clinical Trials Analysis 54
7.7.4 Global Head of Healthcare 55
7.8 About GlobalData 56
7.9 Contact Us 56
7.10 Disclaimer 56